Ultragenyx Pharmaceutical Inc. buy Bank of America Co.
Start price
31.05.24
/
50%
€37.00
Target price
31.05.25
€70.03
Performance (%)
39.19%
Price
29.08.24
€51.00
Summary
This prediction is currently active. With a performance of 39.19% the BUY prediction by Bank_of_America_Co_ is a big success. This prediction currently runs until 31.05.25. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Ultragenyx Pharmaceutical Inc. | 0.990% | 0.990% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Bank of America Co. from $83.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat